Trial reportBMC psychology2025
A feasibility study of scheduling a remission consultation in the management of patients treated for localized breast cancer.
Trial report in BMC psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02740491 (Evaluation of the Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast Cancer), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of the Implementation of a "Remission" Consultation in the Management of Patients Treated for Localized Breast Cancer
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the feasibility of a remission consultation with on-going personalized care for patients treated for localized breast cancer entering a monitoring phase, while collecting quality of life data for one year. The primary objective was to evaluate the rate of acceptance of the remission consultation and, in the group who accepted, evaluate the change in quality of life using the EORTC QLQ-C30 over time. The secondary objectives were to evaluate change over time of the patient's perception of body image via the BIS score, change over time in psychological distress score on a visual analog scale, time until return to work, and to describe the characteristics of patients according to the management methods chosen.
methodsPatients in remission from non-metastatic breast cancer were invited to a one-hour consultation interview to assess psychological condition and identify personalized supportive care needs. Various psychological follow-up options were offered depending on patient needs (e.g., anxiety or depression; fear of recurrence; or difficulty reconnecting with family, friends or at work). Patients were followed up at 3, 6 and 12 months after the remission consultation.
resultsOf the 69 patients included, 50 (72% [95%CI 60-83]) accepted the remission consultation with a psychotherapist, with 27 opting for further follow-up. There was a significant improvement in patients' overall quality of life (p = 0.01), physical functioning (p = 0.002) and body image perception (p = 0.007) over the study. Symptoms (pain, fatigue and dyspnea) significantly decreased over time. The psychological distress score halved, but was not statistically significantly different. The proportion of women returning to work increased over time.
conclusionThis study evaluated acceptance rate of remission consultations and the change in patients' quality of life, well-being and reintegration over one year following the consultation. These results suggest that a remission consultation is feasible and would be well-received by a considerable number of patients. Offering a consultation at this stage represents a first step towards a better psychological management following cancer. These preliminary results require confirmation in a multicenter study with a randomized design. TRIAL REGISTRATION NUMBER: NCT02740491, registered 14 April 2016.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.